Literature DB >> 31808125

Antibiotics: From the Beginning to the Future: Part 2.

Nancy Khardori1, Cecilia Stevaux2, Kathryn Ripley2.   

Abstract

We read, write, and discuss the option of adding new agents to the armamentarium of antibiotic therapy very frequently. However, the past and present has taught us that resistance is likely to develop to any and all kinds of antibiotics. Here we start with an overview of potential future antibiotics from novel sources and targets that may circumvent most known resistance mechanisms. The other future options for antibiotic discovery include antibiotic hybridization, harvesting, and modifying natural antimicrobial peptides from eukaryote and prokaryote organisms. Non bacteriostatic and bactericidal agents that have the potential of becoming therapeutic agents include bacterial attachment inhibitors, bacteriophages, and live microbial vectors. In this review, we have incorporated all the possible avenues that might be useful in the future. However, none is more important than relearning the judicious use of antibiotics based on microbiology, pharmacology, and genetics.

Keywords:  Antibiotic stewardship; Antibiotics; Antimicrobial peptides; Bacteriophages; Resistance

Mesh:

Substances:

Year:  2019        PMID: 31808125     DOI: 10.1007/s12098-019-03113-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  21 in total

1.  Bacteriophage therapy. Stalin's forgotten cure.

Authors:  Richard Stone
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance.

Authors:  Seungsoo Kim; Tami D Lieberman; Roy Kishony
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

3.  Antibiotic misuse: a global crisis.

Authors:  Michael Bell
Journal:  JAMA Intern Med       Date:  2014-12       Impact factor: 21.873

Review 4.  Dual-action antibiotic hybrids.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1994-02       Impact factor: 5.790

Review 5.  Ubiquitous natural antibiotics.

Authors:  J E Gabay
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

Review 6.  Tackling antibiotic resistance.

Authors:  Karen Bush; Patrice Courvalin; Gautam Dantas; Julian Davies; Barry Eisenstein; Pentti Huovinen; George A Jacoby; Roy Kishony; Barry N Kreiswirth; Elizabeth Kutter; Stephen A Lerner; Stuart Levy; Kim Lewis; Olga Lomovskaya; Jeffrey H Miller; Shahriar Mobashery; Laura J V Piddock; Steven Projan; Christopher M Thomas; Alexander Tomasz; Paul M Tulkens; Timothy R Walsh; James D Watson; Jan Witkowski; Wolfgang Witte; Gerry Wright; Pamela Yeh; Helen I Zgurskaya
Journal:  Nat Rev Microbiol       Date:  2011-11-02       Impact factor: 60.633

7.  Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198.

Authors:  Marina D Georgalaki; Erika Van Den Berghe; Dimitrios Kritikos; Bart Devreese; Jozef Van Beeumen; George Kalantzopoulos; Luc De Vuyst; Effie Tsakalidou
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

8.  Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.

Authors:  Deborah T Hung; Elizabeth A Shakhnovich; Emily Pierson; John J Mekalanos
Journal:  Science       Date:  2005-10-13       Impact factor: 47.728

9.  Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.

Authors:  Sophie M Lehar; Thomas Pillow; Min Xu; Leanna Staben; Kimberly K Kajihara; Richard Vandlen; Laura DePalatis; Helga Raab; Wouter L Hazenbos; J Hiroshi Morisaki; Janice Kim; Summer Park; Martine Darwish; Byoung-Chul Lee; Hilda Hernandez; Kelly M Loyet; Patrick Lupardus; Rina Fong; Donghong Yan; Cecile Chalouni; Elizabeth Luis; Yana Khalfin; Emile Plise; Jonathan Cheong; Joseph P Lyssikatos; Magnus Strandh; Klaus Koefoed; Peter S Andersen; John A Flygare; Man Wah Tan; Eric J Brown; Sanjeev Mariathasan
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

10.  Lactic acid bacterial symbionts in honeybees - an unknown key to honey's antimicrobial and therapeutic activities.

Authors:  Tobias C Olofsson; Èile Butler; Pawel Markowicz; Christina Lindholm; Lennart Larsson; Alejandra Vásquez
Journal:  Int Wound J       Date:  2014-09-08       Impact factor: 3.315

View more
  3 in total

1.  Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic's Potentiation in Multi Drug Resistant P. aeruginosa.

Authors:  Pratima Pandey; Rajashree Sahoo; Khusbu Singh; Sanghamitra Pati; Jose Mathew; Avinash Chandra Pandey; Rajni Kant; Ihn Han; Eun-Ha Choi; Gaurav Raj Dwivedi; Dharmendra K Yadav
Journal:  Nanomaterials (Basel)       Date:  2021-12-30       Impact factor: 5.076

Review 2.  Antibiotic Discovery and Resistance: The Chase and the Race.

Authors:  Katia Iskandar; Jayaseelan Murugaiyan; Dalal Hammoudi Halat; Said El Hage; Vindana Chibabhai; Saranya Adukkadukkam; Christine Roques; Laurent Molinier; Pascale Salameh; Maarten Van Dongen
Journal:  Antibiotics (Basel)       Date:  2022-01-30

3.  Resistance to Antibacterial Agents: Foregone Conclusion - What's Next?

Authors:  Chand Wattal; Nancy Khardori
Journal:  Indian J Pediatr       Date:  2019-12-11       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.